We recently compiled a list of the These 10 Companies Led Gains on Wednesday. In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the other stocks.
Wall Street’s main indices ended firmer on Wednesday as share prices remained boosted by positive catalysts from President Donald Trump’s inauguration coupled with better-than-expected earnings performance.
The Dow rose by 0.30 percent, the S&P 500 grew 0.61 percent, while the Nasdaq Composite increased 1.28 percent.
Meanwhile, 10 companies under mixed sectors mirrored Wall Street’s gains. In this article, we will look at which companies led the rally and explore the reasons behind their impressive performance.
To come up with Wednesday’s top gainers, we considered only the stocks with at least $2 billion in market capitalization and $5 million in daily trading volume.
A pharmacist in a hospital pharmacy stands next to a row of various drug containers.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Recursion Pharmaceuticals, Inc., a biotechnology company, reported an 8.87-percent increase in its share prices on Wednesday, a third consecutive day, to finish at $7.49 each.
According to analysts, the firm appears to be earning a boost from the booming AI industry after the Trump administration pledged support to the expansion of the said sector.
At his inauguration event on Monday, President Donald Trump promised that the US government would support the expansion of artificial intelligence through a $500-billion funding.
According to analysts, companies utilizing artificial intelligence to bolster growth, such as Recursion Pharmaceuticals, stand to benefit from the AI expansion.
Recursion Pharmaceuticals is a clinical-stage biotechnology firm leading the space by decoding biology to industrialize drug discovery.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
This article is originally published at Insider Monkey.